Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday, 16 October 2017
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Stephen Opat
et al
. published in the
New England Journal of Medicine.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment